Although several cytokines and chemokines have been demonstrated to play pivotal roles in the pathophysiological conditions of atherosclerosis, few findings exist regarding the expression and function of cytokine-modulating molecules such as ephrin-Bs and their cognate receptors, EphBs, in human atherosclerosis. Therefore, in the present study, we screened novel genes modulating atherogenesis by cDNA array and quantitatively determined them by real-time RT (reverse transcription)-PCR in human carotid atherosclerotic plaques. Ephrin-B1 and EphB2, key regulators of embryogenesis, were significantly up-regulated in plaques compared with those in adjacent control tissues [ephrin-B1, 0.638±0.106 compared with 0.831±0.152, or 130% (P<0.05); EphB2, 1.296±0.281 compared with 2.233±0.506, or 172% (P<0.05)]. Immunohistological analysis demonstrated that both ephrin-B1 and EphB2 were expressed in macrophages and T-lymphocytes in plaques as well as in monocytes, T-lymphocytes and arterial endothelial cells isolated from healthy adults. Interestingly, the extracellular domains of ephrin-B1 and EphB2, the expression of which were both enhanced in stimulated THP-1 cells, significantly inhibited spontaneous (22.5 and 27.6% respectively; P<0.01) and MCP-1 (monocyte chemoattractant protein-1)-dependent (29.7 and 22.6% respectively; P<0.01) migration of monocytes. In conclusion, these results demonstrate that ephrin-B1 and EphB2 are overexpressed in atherosclerotic tissue and might locally regulate cell migration, possibly through modulating cytokine-related chemotaxic activity; however, the functional role of these molecules in atherogenesis should be investigated further.
Skip Nav Destination
Article navigation
May 2008
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
April 14 2008
Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis
Aiji Sakamoto;
Aiji Sakamoto
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Hatsue Ishibashi-Ueda;
Hatsue Ishibashi-Ueda
†Division of Pathology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Yuka Sugamoto;
Yuka Sugamoto
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Takeo Higashikata;
Takeo Higashikata
*Division of Biotechnology, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Susumu Miyamoto;
Susumu Miyamoto
‡Division of Neurosurgery, National Cardiovascular Center, Osaka, Japan
Search for other works by this author on:
Masa-aki Kawashiri;
Masa-aki Kawashiri
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Kunimasa Yagi;
Kunimasa Yagi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Tetsuo Konno;
Tetsuo Konno
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Kenshi Hayashi;
Kenshi Hayashi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Noboru Fujino;
Noboru Fujino
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Hidekazu Ino;
Hidekazu Ino
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Yoshiyu Takeda;
Yoshiyu Takeda
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Search for other works by this author on:
Masakazu Yamagishi
§Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Ishikawa, Japan
Correspondence: Dr Masakazu Yamagishi (email myamagi@med.kanazawa-u.ac.jp).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
September 25 2007
Revision Received:
November 15 2007
Accepted:
December 19 2007
Accepted Manuscript online:
December 19 2007
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2008 Biochemical Society
2008
Clin Sci (Lond) (2008) 114 (10): 643–650.
Article history
Received:
September 25 2007
Revision Received:
November 15 2007
Accepted:
December 19 2007
Accepted Manuscript online:
December 19 2007
Citation
Aiji Sakamoto, Hatsue Ishibashi-Ueda, Yuka Sugamoto, Takeo Higashikata, Susumu Miyamoto, Masa-aki Kawashiri, Kunimasa Yagi, Tetsuo Konno, Kenshi Hayashi, Noboru Fujino, Hidekazu Ino, Yoshiyu Takeda, Masakazu Yamagishi; Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. Clin Sci (Lond) 1 May 2008; 114 (10): 643–650. doi: https://doi.org/10.1042/CS20070339
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.